_edited.png)
About Us
Introduction
Ensite Vascular LLC
At EnsiteVascular, innovation drives us. Our team, composed of industry changemakers, has developed SiteSeal® and SiteSeal® SV™ - revolutionary devices addressing the complexities of vascular closure. We're not just adding another VCD to the market; we're setting a new standard, focusing on impeccable outcomes for an increasing number of patients with vascular diseases.
Our Mission
To revolutionize vascular closures, ensuring every patient benefits from our commitment to leave nothing behind.
Meet Our Founders:
With over 35 years in medical diagnostics, Tom, our CEO, brings a wealth of experience from leading Primus Corporation and co-founding several successful enterprises.
Tom J. Reidy
Founder / CEO
A Cornell-educated chemical engineer and EVP of Engineering at Absolute Aeration, LLC, Chip holds over 35 U.S. patents and has a rich background in R&D from Tropicana to Procter & Gamble.
Chip Beetle
Founder / VP of Engineering
A Tulane University alumnus and a veteran Vascular and Interventional Radiologist, Dr. Teeslink has pioneered interventional procedures and contributed extensively to medical education and device innovation.
Rex Teeslink
Founder / Chief Medical Officer
Tom Reidy
Tom Reidy is a seasoned serial entrepreneur with over 35 years of expertise in medical diagnostics. As the CEO of Ensite Vascular, he leverages his vast experience, previously guiding Primus Corporation as President and CEO before its sale. Reidy co-founded Immuno Biotech, RESA Enterprises, and AID Laboratories, demonstrating a consistent track record of visionary leadership and successful enterprise management.
Ensite Vascular LLC
The Time Had Come for a New Approach to Vascular Closure:
Meet Our Founders
Ensite Vascular is led by status quo changers who seek innovation in medical devices like VCDs. SiteSeal® and SiteSeal SV® are breakthrough devices that solve the challenges of establishing hemostasis for endovascular physicians, patients, and healthcare administrators alike. The time had come for a new approach to vascular closures, and Ensite Vascular’s VCDs are the result.
For us, it’s not about putting another VCD on the market; It’s about leaving nothing behind. Because in our niche medical device market, the number of patients with coronary and peripheral arterial disease and structural heart disease is increasing. And if we can make vascular closure outcomes better for everyone, then that's what we're going to do.
Rex Teeslink
Dr. Rex Teeslink, a distinguished Tulane University School of Medicine graduate, is a Vascular and Interventional Radiologist with over 40 years of experience. Renowned for pioneering interventional procedures, he has held key roles at Medical College of Georgia and various hospitals, while contributing significantly to medical education and device innovation.
Chip Bettle
Chip Bettle, a Cornell-educated chemical engineer, is the EVP of Engineering at Absolute Aeration, LLC and a prolific innovator with over 35 U.S. patents. With extensive experience at Tropicana and Procter & Gamble, he has made significant contribution to R&D in areas from detergent technology to advanced wound care.
